To report the 12-month results of the first head-to-head comparison of a dexamethasone implant ( Ozurdex ; Allergan , Inc. , Irvine , CA ) versus bevacizumab ( Avastin ; Genentech , South San Francisco , CA ) for center-involving diabetic macular edema ( DME ) .